In a statement, the Danish company said the move would help to address "access barriers" to the medicines and "make it easier and more affordable for people in the US to get authentic, FDA-approved Wegovy and Ozempic in the way that best fits their lives." There's little doubt that one of the reasons for the move will be to try to keep pace with arch-rival Eli Lilly in the market for incretin-based therapies for obesity and T2D, particularly the strong growth of Lilly's dual GIP/GLP-1 agonist tirzepatide, whose growth rate is outstripping Novo Nordisk's products
Beyond weight management, Semaglutide also targets type 2 diabetes, offering a comprehensive solution for improved health outcomes
Recovery + Fat Loss: Wolverine Blend + Tesamorelin This stack pairs the tissue repair and recovery mechanisms of the Wolverine Blend with the visceral fat reduction and metabolic optimization focus of Tesamorelin
Wash hands and clean injection site with alcohol
This helps reduce muscle soreness, shorten recovery time, and boost energy levels, allowing you to train harder and perform at your peak